Sterling Pharma Solutions
NDC Database
Sterling Pharma Solutions
NDC Database
National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.
- Total Records 42
- Latest Marketing Date 2025-06-09
- Data Source FDA
- First Marketing Date 1994-03-25
Company Overview
Social Profiles
Company Snapshot
Sterling Pharma Solutions
Sterling Place, Dudley Cramlington, Northumberland, NE23 7QG
United Kingdom
www.sterlingpharmasolutions.com/ View on MapNDC Records ( 42 records )
Nonproprietary Name
Dexmedetomidine Hydrochloride
Dosage Form
POWDER
Strength
350 g/350g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
DEXMEDETOMIDINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2009-03-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Isradipine
Dosage Form
POWDER
Strength
2500 g/2500g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
ISRADIPINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2003-08-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fenoldopam mesylate
Dosage Form
POWDER
Strength
300 g/300g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
FENOLDOPAM MESYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2002-09-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Deoxycholic Acid
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
DEOXYCHOLIC ACID
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2015-04-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Anagrelide Hydrochloride, Hydrate
Dosage Form
POWDER
Strength
3 kg/3kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
ANAGRELIDE HYDROCHLORIDE MONOHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2003-11-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dexrazoxane
Dosage Form
POWDER
Strength
450 g/450g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
DEXRAZOXANE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2005-05-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Taurolidine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
TAUROLIDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mebrofenin
Dosage Form
POWDER
Strength
5000 g/5000g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
MEBROFENIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2006-03-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
fuzapladib sodium
Dosage Form
POWDER
Strength
7 kg/7kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
IS-741 SODIUM MONOHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2022-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acrivastine
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
ACRIVASTINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
1994-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sodium Thiosulfate Pentahydrate
Dosage Form
POWDER
Strength
60 kg/60kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
SODIUM THIOSULFATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2019-05-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Avatrombopag Maleate
Dosage Form
POWDER
Strength
19 kg/19kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
AVATROMBOPAG MALEATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2022-12-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Isoproterenol Hydrochloride
Dosage Form
POWDER
Strength
340 g/340g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
ISOPROTERENOL HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-06-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Avatrombopag Maleate
Dosage Form
POWDER
Strength
19 kg/19kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
AVATROMBOPAG MALEATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-06-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Methylenediphosphonic Acid
Dosage Form
INJECTION
Strength
1000 g/1000g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
MEDRONIC ACID
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2020-11-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Grapiprant
Dosage Form
POWDER
Strength
100 kg/100kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
GRAPIPRANT
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2015-01-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fomepizole
Dosage Form
LIQUID
Strength
2000 g/2000g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
FOMEPIZOLE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2006-02-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tetrakis(2-methoxy isobutyl isonitrile) copper(I) tetrafluoroborate
Dosage Form
POWDER
Strength
400 g/400g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2009-07-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Oliceridine Fumarate
Dosage Form
INJECTION, SOLUTION
Strength
20 kg/20kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
OLICERIDINE
Product Type
BULK INGREDIENT
DEA Schedule
CII
Start Marketing Date
2020-08-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pexidartinib HCl
Dosage Form
POWDER
Strength
20 kg/20kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
PEXIDARTINIB HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2019-08-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Midodrine Hydrochloride
Dosage Form
POWDER
Strength
25 kg/25kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
MIDODRINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2003-03-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Midodrine Hydrochloride
Dosage Form
POWDER
Strength
25 kg/25kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
MIDODRINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2003-03-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mebrofenin
Dosage Form
POWDER
Strength
2000 g/2000g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
MEBROFENIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2006-03-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
Dosage Form
POWDER
Strength
1 g/g
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-01-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Iloperidone
Dosage Form
POWDER
Strength
86 kg/86kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
ILOPERIDONE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2009-05-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
TAZEMETOSTAT HYDROBROMIDE
Dosage Form
POWDER
Strength
160 kg/160kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
TAZEMETOSTAT HYDROBROMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2020-01-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levalbuterol Tartrate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
LEVALBUTEROL TARTRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2005-03-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levalbuterol Tartrate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
LEVALBUTEROL TARTRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2005-03-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Arformoterol Tartrate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
ARFORMOTEROL TARTRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2006-10-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Toceranib Phosphate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
TOCERANIB PHOSPHATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2009-05-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Selamectin
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
SELAMECTIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
1999-05-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Zileuton
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
ZILEUTON
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
1996-12-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Diroximel fumarate
Dosage Form
POWDER
Strength
12 kg/12kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
DIROXIMEL FUMARATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2019-10-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ractopamine Hydrochloride
Dosage Form
SUSPENSION
Strength
1 kg/kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RACTOPAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-07-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ferric Maltol
Dosage Form
POWDER
Strength
550 kg/550kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
FERRIC MALTOL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2019-07-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan
Dosage Form
POWDER
Strength
400 kg/400kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
VALSARTAN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-07-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Imatinib mesylate
Dosage Form
POWDER
Strength
640 kg/640kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
IMATINIB MESYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-07-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ciclosporin
Dosage Form
POWDER
Strength
307 kg/307kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
CYCLOSPORINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-07-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Octreotide acetate
Dosage Form
POWDER
Strength
3 kg/3kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
OCTREOTIDE ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-07-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Capmatinib Hydrochloride
Dosage Form
POWDER
Strength
90 kg/90kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
CAPMATINIB HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-07-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dabrafenib Mesylate
Dosage Form
POWDER
Strength
10 kg/10kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
DABRAFENIB MESYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-07-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Nilotinib Hydrochloride
Dosage Form
POWDER
Strength
350 kg/350kg
Labeler
Sterling Pharma Solutions Limited
Marketing Category
BULK INGREDIENT
Substance
NILOTINIB HYDROCHLORIDE MONOHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-07-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
42 View
-
FDA Approved Drugs Database
0 View
-
Drug Prices in Switzerland
0 View
NDC Type Breakdown
42 total- Bulk Ingredient
- Drug for Further Processing
Official Source
NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).
Visit FDA NDC DirectoryNDC Record Details Preview
Explore important National Drug Code information available in the records above.
NDC
50384-0100
Nonproprietary Name
Dexmedetomidine Hydrochloride
Labeler
Sterling Pharma Solutions Limited
Dosage Form
POWDER
FDA NDC Data
National Drug Code information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized NDC records
Create a New Buying Request
Fields marked with * are mandatory.